FDA approves synthetic swabs for Covid-19 testing in United States
The US Food and Drug Administration said on Thursday produced synthetic swabs could be used for coronavirus testing by collecting a sample from the front of the nose.
This type of testing would allow self-collection by patients, thereby restricting exposure of healthcare providers, FDA said.
The United States has recorded more fatalities from COVID-19, the respiratory disease caused by the new coronavirus, than any other country, with 30,961 deaths and 636,937 confirmed cases.
US Cotton, the largest manufacturer of cotton swabs in the country, developed a polyester-based Q-tip-type swab that is full unity with COVID-19 testing, FDA said.
“US Cotton plans to produce these new polyester swabs in large quantities to help meet the needs for coronavirus diagnostic testing,” the regulator said in a statement.
The finding that spun synthetic swabs could be used for testing is based on results from a clinical investigation by the FDA, UnitedHealth Group, the Gates Foundation, and Quantigen.
Author Profile
Monika Walker is a senior journalist specializing in regional and international politics, offering in-depth analysis on governance, diplomacy, and key global developments. With a degree in International Journalism, she is dedicated to amplifying underrepresented voices through factual reporting. She also covers world news across every genre, providing readers with balanced and timely insights that connect the Caribbean to global conversations.
Latest
- Construction worker charged with possession of prohibited we...
-
Three Trinidad police officers charged with $6,000 bribery s... -
Two motorcyclists killed in head-on collision on Bussu Lane,... -
Tobago sees alarming drop in birth rate, declines from 1,000... -
Belize City Tragedy: 4-year-old Kyra Bennett dies in Arlingt...
